Product Description

🔹 Product Overview
Euvifol-HP 150 IU Injection is a fertility medicine containing Urofollitropin 150 IU, a purified form of follicle-stimulating hormone (FSH). It belongs to the gonadotropin class of medicines and is used in specialist fertility treatment to stimulate the development of ovarian follicles.
The medicine may be prescribed for women experiencing ovulation-related infertility and may also form part of an assisted reproductive technology (ART) treatment plan, including IVF. Treatment requires medical monitoring because the dose and duration are individualized according to ovarian response.
Active ingredient: Urofollitropin 150 IU
Drug class: Gonadotropin / Follicle-stimulating hormone (FSH)
Dosage form: Powder/solution for injection

🔹 Key Uses
Euvifol-HP 150 IU may be prescribed for:
Female infertility associated with ovulation problems
Stimulation of ovarian follicle development
Ovulation-induction treatment in appropriately selected patients
Assisted reproductive techniques such as IVF, where stimulation of multiple follicles may be required
The exact indication and treatment protocol should be determined by a fertility specialist.

🔹 Composition
Active ingredient: Urofollitropin 150 IU
Urofollitropin is a purified form of follicle-stimulating hormone (FSH). FSH plays an important role in the development and maturation of ovarian follicles.

🔹 How It Works
Euvifol-HP 150 IU works by providing FSH activity that stimulates the ovaries.
It promotes the growth and development of ovarian follicles, the structures in which eggs develop. As follicles mature, estrogen production increases as part of the normal ovarian response.
In fertility-treatment protocols, the response is monitored using methods such as ultrasound and, when appropriate, hormone testing. The treatment may subsequently be combined with other fertility medicines according to the patient's treatment plan.

🔹 Key Benefits
Supports ovarian follicle development
Helps stimulate ovarian response in selected infertility treatments
Can be incorporated into medically supervised ovulation-induction protocols
May be used as part of controlled ovarian stimulation for IVF and other ART procedures
Important: Euvifol-HP 150 IU does not guarantee pregnancy. Treatment success depends on several individual and clinical factors.

🔹 Dosage and Administration
The dose, treatment duration and timing are individualized by the fertility specialist based on the patients age, ovarian reserve, diagnosis and response to treatment.
Euvifol-HP 150 IU is administered by injection. Depending on the specific formulation and prescribing instructions, administration may be performed by a healthcare professional or according to a fertility clinics trained self-administration protocol.
Do not change the dose, injection schedule or treatment duration without medical advice.
Patients receiving this medicine generally require regular monitoring to assess follicular development and reduce the risk of excessive ovarian stimulation.

🔹 Possible Side Effects
Possible side effects may include:
Headache
Nausea
Abdominal discomfort or pain
Pelvic discomfort
Bloating
Injection-site pain or irritation
Hot flushes
Fatigue or tiredness
Fertility medicines containing FSH can cause ovarian hyperstimulation syndrome (OHSS) in some patients. Severe abdominal pain, significant abdominal swelling, persistent nausea/vomiting, rapid weight gain or breathing difficulties require prompt medical assessment.

🔹 Precautions
Before treatment, inform your doctor if you have:
Ovarian cysts or ovarian enlargement
Unexplained vaginal bleeding
A history of hormone-dependent or reproductive-system conditions
Thyroid, adrenal or pituitary disorders
Any known allergy to gonadotropin medicines
Previous problems with fertility medicines